slide1 n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
About the study PowerPoint Presentation
Download Presentation
About the study

Loading in 2 Seconds...

play fullscreen
1 / 12

About the study - PowerPoint PPT Presentation


  • 92 Views
  • Uploaded on

“Australia is #1 site to conduct clinical trials” Summary of Economist Intelligence Unit Report: Benchmarking Study of the Characteristics of the Australian and International Pharmaceutical Industries Sep 2005. About the study. Independent study conducted by Economist Intelligence Unit

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'About the study' - adena-cantrell


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide1

“Australia is #1 site to conduct clinical trials”Summary of Economist Intelligence Unit Report: Benchmarking Study of the Characteristics of the Australian and International Pharmaceutical IndustriesSep 2005

about the study
About the study
  • Independent study conducted by Economist Intelligence Unit
  • Commissioned by Australian Govt. Dept. Industry Tourism & Resources, Invest Australia, Victorian Govt. Dep. Innovation, Industry & Regional Development
  • Benchmarked Australian Industry versus:
    • USA
    • UK
    • Germany
    • Japan
    • Singapore
    • India

Full report available at: www.industry.gov.au

clinical trials benchmarking
Clinical Trials Benchmarking

Aggregate Benchmark Scores

What is driving Australia’s performance?

driven by low average cost per patient and high availability of research sites
Driven by low average cost per patient and high availability of research sites…

Average cost per patient

# sites per 100,000 pop.

$6,712 (USA) to $2,500 (India)

$3,984 (Australia)

25,000 (USA) to 11 (Singapore)

2,500 (Australia)

source: CentreWatch

good participation rates and high on time completion rates
…Good participation rates andhigh on-time completion rates…

# patients in trials per 100,000 pop.

% Studies completed on time

3,600,000 (USA) to 3,745 (India)

20,000 (Australia)

85% (India) to 10%(USA)

80% (Australia)

source: CentreWatch

with a capacity to do more
…with a capacity to do more...

#Phase I per 100,000 pop.

#Phase II per 100,000 pop.

#Phase III per 100,000 pop.

#Other Phase per 100,000 pop.

Other includes Phase IV, medical device, bioequivalence

and a quality workforce
…and a quality workforce

Pharma Industry skilled professionals per 100,000 LF.

#Graduate degrees per 100,000 LF.

Regulatory & Quality Systems

Govt. Initiatives & Incentives

Other includes Phase IV, medical device, bioequivalence

snapshot of australian pharma biotechnology industry
Snapshot of Australian Pharma & Biotechnology Industry
  • Pharma company sales in Australia $6b (1.2% of world market)
      • 93% prescription sales covered under PBS (Govt. funded)
      • 57% having some degree of local manufacture
  • Export sales of Pharmaceuticals $2.4b
  • 421 Core biotechnology companies (83 listed)
      • Market cap $4.3b (ex. CSL)
  • 612 Medical device companies (45 listed)
      • Market cap $9.0b

Source: Bioindustry Review 2006

australian biotech sector is very active in forming alliances
Australian Biotech sector is very active in forming alliances

28% Internal

36% North America

2% Africa

3% NZ/Pacific

12% Asia

19% Europe

  • 112 alliances formed with US companies in 2005
  • Australian Biotechs purchased 24 overseas companies

Source: Bioindustry Review 2006

key takeaways
Key Takeaways:
  • Australia is an excellent location for conducting clinical research
  • Australia has a vibrant Biotech & pharmaceutical sector
  • Australian companies want to work with international partners